ECT vs. ketamine for suicidal depression in adults
Part of Mental health clinical trials.
This trial compares two treatments—ECT (electroconvulsive therapy, which uses electrical stimulation) and ketamine (a medicine given as a shot)—to see which works better for quickly reducing suicidal depression. It is for adults who are in a severe depressive episode with active suicidal thoughts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 90 years old.
- You have major depression and are currently having suicidal thoughts or have recently attempted suicide.
- You do not have schizophrenia or a related psychotic disorder.
- You are not pregnant or breastfeeding (if applicable).
- You are able to give informed consent and follow study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding ketamine to electroconvulsive therapy (ECT) works better than ECT alone for people with depression that hasn't improved with at least two different antidepressants. It may offer a new option for those who have not found relief from standard treatments.
This study tests if ketamine can help reduce suicidal thoughts in people with major depression. You'll receive ketamine treatment and be monitored closely.
This study tests whether adding a low dose of esketamine (a type of anesthesia) to modified electroconvulsive therapy (ECT) helps treat severe depression in teenagers. It aims to see if this combination works better and is safer than ECT alone.
This trial tests if esketamine (a nasal spray) can quickly reduce symptoms of major depression and suicidal thoughts in teenagers who need urgent hospital care.
This trial tests if a ketamine injection under the skin (subcutaneous) can safely help teenagers with severe depression and suicidal thoughts or actions. It is for teens who are already receiving standard depression treatment but still have high symptom scores.
This trial tests if a single dose of ketamine can quickly reduce suicidal thoughts in people who come to the emergency department. If you are having active suicidal thoughts and need inpatient care, you may be able to join.
Hear when a new Acute Suicidal Depression (ASD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.